FluoGuide Enrolls First Patient in U.S. Phase 2 Trial of FG001 in High-Grade Glioma

FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotechnology company focused on precision cancer surgery, today announced that the first patient has been enrolled in FG001-CT-006, the Company's U.S. Phase 2 clinical trial of FG001 in …